checkAd

     618  0 Kommentare iHeart Radio's "HealthTech Talk" Show to Feature MYOS Corporation's Ingredient Fortetropin(TM) in Exclusive Interview With Company Chairman

    CEDAR KNOLLS, NJ--(Marketwired - Mar 6, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance, announced today that its Chairman of the Board, Dr. Robert J. Hariri, will be interviewed live on iHeart Radio's Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios -- 640 WGST AM tomorrow, at 3:00pm ET.

    In this exclusive interview, Dr. Hariri will discuss the Company's all-natural ingredient, Fortetropin™, the first clinically demonstrated myostatin inhibitor, and soon-to-be launched product line RE, the Company's 2014 milestones and touch on MYOS's 2015 outlook and the recent outspoken celebrity attention MYOS has been garnering from Justin Bieber and the world's strongest man. Fortetropin™ is manufactured to optimize biological activity to build healthy lean muscle. MYOS believes Fortetropin™ has the potential to redefine existing standards for muscle health and human longevity.

    MYOS encourages all shareholders, analysts, industry professionals and interested parties to tune in live to the interview with Dr. Hariri. The details and link to iHeart Radio's live worldwide stream are below.

    Date: March 7, 2015 
    Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT 
    Network: iHeart Radio/ Clear Channel
    Station: 640 WGST AM
    Show: Health Tech Talk Live
    Host: Ben Chodor
    iHeart Radio Live Stream: CLICK HERE

    About iHeart Radio/ Clear Channel
    Clear Channel's Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information about please visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

    Seite 1 von 4




    Verfasst von Marketwired
    iHeart Radio's "HealthTech Talk" Show to Feature MYOS Corporation's Ingredient Fortetropin(TM) in Exclusive Interview With Company Chairman CEDAR KNOLLS, NJ--(Marketwired - Mar 6, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve …